Trial
NCT04385849
Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
COVID-19
Intervention
N-803
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-05